In this study, we investigate the synergistic effects of FAM46C expression with the selective SphK1 inhibitor PF-543 both in vitro, in MM cell lines, and in vivo, in a mouse xenograft model. This evidence concerns the gene SPHK1 and Miyoshi myopathy.